Related Experiment Videos
Neurotrophic factors and amyotrophic lateral sclerosis
1Department of Neurology, University of Southern California School of Medicine, Hospital of the Good Samaritan, Los Angeles 90017-1912, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Neuropathology and applied neurobiology·2013
Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2007
Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2006
Sporadic inclusion-body myositis: a proposed key pathogenetic role of the abnormalities of the ubiquitin-proteasome system, and protein misfolding and aggregation.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2005
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Regenerative medicine for neurodegenerative diseases:History, Strategies, and Clinical Advances.
Translational research : the journal of laboratory and clinical medicine·2026
Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK/STAT and TGFβ/SMAD signaling crosstalk.
Biochimica et biophysica acta. General subjects·2026
Safety and adverse event profiles in neuromodulation therapies for drug-resistant epilepsy.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026